Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives

Nucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents. For their ability to compete with physiological nucleosides, NAs act as antimetabolites exerting their activity by interfering with the s...

Full description

Bibliographic Details
Main Authors: Federica De Castro, Erika Stefàno, Erik De Luca, Michele Benedetti, Francesco Paolo Fanizzi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/3/941
_version_ 1827748044675743744
author Federica De Castro
Erika Stefàno
Erik De Luca
Michele Benedetti
Francesco Paolo Fanizzi
author_facet Federica De Castro
Erika Stefàno
Erik De Luca
Michele Benedetti
Francesco Paolo Fanizzi
author_sort Federica De Castro
collection DOAJ
description Nucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents. For their ability to compete with physiological nucleosides, NAs act as antimetabolites exerting their activity by interfering with the synthesis of nucleic acids. Much progress in the comprehension of their molecular mechanisms has been made, including providing new strategies for potentiating anticancer/antiviral activity. Among these strategies, new platinum-NAs showing a good potential to improve the therapeutic indices of NAs have been synthesized and studied. This short review aims to describe the properties and future perspectives of platinum-NAs, proposing these complexes as a new class of antimetabolites.
first_indexed 2024-03-11T06:02:48Z
format Article
id doaj.art-f7486f30b5d54869bc94a68b9658e47c
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T06:02:48Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-f7486f30b5d54869bc94a68b9658e47c2023-11-17T13:16:33ZengMDPI AGPharmaceutics1999-49232023-03-0115394110.3390/pharmaceutics15030941Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and PerspectivesFederica De Castro0Erika Stefàno1Erik De Luca2Michele Benedetti3Francesco Paolo Fanizzi4Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyDipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, ItalyNucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents. For their ability to compete with physiological nucleosides, NAs act as antimetabolites exerting their activity by interfering with the synthesis of nucleic acids. Much progress in the comprehension of their molecular mechanisms has been made, including providing new strategies for potentiating anticancer/antiviral activity. Among these strategies, new platinum-NAs showing a good potential to improve the therapeutic indices of NAs have been synthesized and studied. This short review aims to describe the properties and future perspectives of platinum-NAs, proposing these complexes as a new class of antimetabolites.https://www.mdpi.com/1999-4923/15/3/941nucleoside analoguesplatinum compoundscoordination compoundsantitumor drugsantiviral drugsantimetabolites
spellingShingle Federica De Castro
Erika Stefàno
Erik De Luca
Michele Benedetti
Francesco Paolo Fanizzi
Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
Pharmaceutics
nucleoside analogues
platinum compounds
coordination compounds
antitumor drugs
antiviral drugs
antimetabolites
title Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
title_full Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
title_fullStr Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
title_full_unstemmed Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
title_short Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives
title_sort platinum nucleos t ide compounds as possible antimetabolites for antitumor antiviral therapy properties and perspectives
topic nucleoside analogues
platinum compounds
coordination compounds
antitumor drugs
antiviral drugs
antimetabolites
url https://www.mdpi.com/1999-4923/15/3/941
work_keys_str_mv AT federicadecastro platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives
AT erikastefano platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives
AT erikdeluca platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives
AT michelebenedetti platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives
AT francescopaolofanizzi platinumnucleostidecompoundsaspossibleantimetabolitesforantitumorantiviraltherapypropertiesandperspectives